Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for September 9th, 2012

« Older Entries

Jazz For Prostate Cancer Awareness™ – promotional video

By on Sunday, September 9th, 2012 | No Comments

Jazz for Prostate Cancer Awareness is a fundraising campaign strategy that brings music venues, top musicians and non-profit organizations together to create a synergy that brings awareness to this disease. With the appeal and ministry of live inspirational music, Jazz4PCA’s mission is to raise funds for free cancer screenings while raising awareness for prostate cancer and its risk factors.

Read More...

Cancer doctors start at Augusta Health

By on Sunday, September 9th, 2012 | No Comments

The new oncologist, who will begin seeing patients at Augusta Health’s Cancer Center on Monday, has been attending the hospital’s orientation session for new employees.

Read More...

Cancer Society sets next session

By on Sunday, September 9th, 2012 | No Comments

Women who are dealing with the physical changes brought on by cancer treatments can learn new makeup techniques during a session Monday of “Look Good, Feel Better” at Enloe Cancer Center.

Read More...

Cancer Center To Sequence Genomes [Albuquerque Journal, N.M.]

By on Sunday, September 9th, 2012 | No Comments

Via Acquire Media NewsEdge) Sept. 09–The University of New Mexico Cancer Center this fall will be among the first 20 sites worldwide to acquire a technology that can sequence an entire human genome in half a day for about $1,000, giving doctors a powerful new tool for diagnosing and treating cancer, UNM researchers said.

Read More...

MD Anderson study finds biologic therapies for rheumatoid arthritis not associated with increased cancer risk

By on Sunday, September 9th, 2012 | No Comments

Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.

Read More...

MD Anderson study identifies novel therapeutic targets for small cell lung cancer

By on Sunday, September 9th, 2012 | No Comments

Newly discovered molecular differences between small cell lung cancer and non-small cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a University of Texas MD Anderson study published in Cancer Discovery, a journal of the American Association for Cancer Research.

Read More...

Stanford study finds Hispanic lung cancer patients have higher survival than non-Hispanic white patients

By on Sunday, September 9th, 2012 | No Comments

Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival compared to non-Hispanic white patients, according to Stanford University research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. Stanford University is home to the Stanford Cancer Institute.

Read More...

Standard chemotherapy provides equivalent survival rate to experimental in lung cancer patients

By on Sunday, September 9th, 2012 | No Comments

Treatment with pemetrexed, carboplatin, and bevacizumab followed by maintenance pemetrexed and bevacizumab is no better than standard therapy with paclitaxel, carboplatin, and bevacizumab followed by bevacizumab in patients with advanced non-squamous, non-small cell lung cancer, according to Northwestern University research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. Northwestern University is home to the Robert H. Lurie Comprehensive Cancer Center.

Read More...

Christopher Hitchens writes ‘dispatches from Cancerland’ in posthumous memoir

By on Sunday, September 9th, 2012 | No Comments

Certainly the final act was, the in-the-end-sudden switch off, but until then, despite the ignobility of treatment, the actual process leading up to it left him intact.

Read More...

India generics giant Cipla claims big victory in cancer drug patent case

By on Sunday, September 9th, 2012 | No Comments

Indian generics giant Cipla says it has scored a “landmark” court win in a patent challenge launched by Switzerland’s Roche Holding over the Mumbai firm’s version of a lung-cancer drug.

Read More...
« Older Entries